Vera B. B.
- Country
- Germany
- Department
- Dr.v.Haunersches Kinderspital, Abteilung für Onkologie / Hämatologie
Research Overview
- Reduced‑intensity post‑induction chemotherapy plus blinatumomab versus standard post‑induction therapy in pediatric standard‑risk B‑ALL (AIEOP‑BFM ALL 2025)
- International multicenter, open-label clinical trial for the treatment of acute myeloid leukemia in children and adolescents
- Long-Term Follow-up of Patients Treated with Miltenyi Cell and Gene Therapies
Data & Insights
Has run more than one trial at 94 of 183 partner sites.
Specializations
Pediatric Leukemia Research
This investigator specializes in treating acute lymphoblastic leukemia and acute myeloid leukemia in children and adolescents, with particular emphasis on high-risk and relapsed cases.
- Philadelphia chromosome-positive ALL
- B-lineage leukemia
- Myeloid leukemia in Down syndrome
The investigator focuses on developing innovative treatment approaches for challenging leukemia variants in pediatric populations.
Lymphoma Studies
The researcher has significant involvement in treating mature aggressive B-cell lymphoma and lymphoblastic lymphoma in young patients.
- B-cell non-Hodgkin lymphoma
- Advanced stage lymphomas
- CNS involvement in lymphomas
Their work encompasses various stages of lymphoma presentation, from limited disease to advanced cases requiring intensive therapy.
Rare Pediatric Tumors
The investigator conducts research on atypical teratoid/rhabdoid tumors in children, focusing on age-specific treatment approaches.
- Early childhood brain tumors
- Consolidation therapy strategies
- Age-adapted treatment protocols
Their expertise extends to developing specialized protocols for rare aggressive childhood cancers requiring complex therapeutic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.